Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
186.80    0.20 (0.11%)
Bid:
186.40
Ask:
186.60
Spread: 0.20 (0.107%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Trading Update

8 Sep 2021 09:36

RNS Number : 1062L
B&M European Value Retail S.A.
08 September 2021
 

 

 

 

8 September 2021

B&M European Value Retail S.A.

 

H1 FY22 Trading Update

 

 

B&M European Value Retail S.A. ("the Group"), the UK's leading variety goods value retailer, today provides a trading update relating to its performance to date for the half year ending 25 September 2021 ("H1 FY22").

 

Whilst Group revenues year to date have been broadly in line with market expectations, gross margins have been stronger than originally anticipated in the B&M UK fascia business.

 

Performance of General Merchandise and Seasonal categories has been particularly encouraging. Sell-through rates in those categories have been high and accordingly end of season markdowns have been limited.

 

As a consequence, the Group now expects adjusted EBITDA1 (on a pre-IFRS16 basis) for H1 FY22 (covering the 26 week period to 25 September 2021) to be in the range of £275m to £285m. The analysts' consensus estimate2 for H1 FY22 adjusted EBITDA1 is currently approximately £235m.

 

Although the Group is well positioned for the upcoming Golden Quarter, trading patterns and strength of customer demand remain highly uncertain for the balance of FY22.

 

The Group will provide further detail in its FY22 Interim Results on 11 November 2021.

 

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation.

 

 

1. The Directors consider adjusted EBITDA figures to be more reflective of the underlying business performance of the Group and believe that this measure provides additional useful information for investors on the Group's performance. Adjusting items are the effects of derivatives, one off refinancing fees, foreign exchange on the translation of intercompany balances and the effects of revaluing or unwinding balances related to the acquisition of subsidiaries.

2. The consensus estimate for adjusted EBITDA in H1 FY22 is based upon the average of 10 analysts who have provided estimates for that period.

 

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400 ext 5763

Simon Arora, Chief Executive

Alex Russo, Chief Financial Officer

Jonny Armstrong, Head of Investor Relations

Investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Sam Cartwright, Maitland

bmstores-maitland@maitland.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGIGDCXXGDGBI
Date   Source Headline
20th Aug 20259:00 amRNSDirector/PDMR Shareholding
14th Aug 20255:30 pmRNSDirector/PDMR Exercise of Share Options
1st Aug 202510:00 amRNSDirector/PDMR Shareholding
30th Jul 20259:00 amRNSDirector/PDMR Shareholding
23rd Jul 20259:01 amRNSResult of EGM
23rd Jul 20259:00 amRNSResult of AGM 22 July 2025
22nd Jul 20254:00 pmRNSTR1 Major Shareholdings in Company
21st Jul 20258:00 amRNSBlock Listing Application
16th Jul 20256:00 pmRNSTR1: Major Shareholding Notification
15th Jul 20257:00 amRNSPositive Quarterly LFL Trading Performance
14th Jul 20255:30 pmRNSBlock Listing Six Monthly Return
3rd Jul 20259:00 amRNSTR1: Major Holdings in Company
3rd Jul 20259:00 amRNSTR1: Major Holdings in Company
27th Jun 202511:00 amRNSTR1: Major Holdings in Company
24th Jun 202510:00 amRNSNotice of FY26 Q1 Trading Statement
19th Jun 20254:30 pmRNSDirector Purchase of Shares
19th Jun 20257:00 amRNSNotice of EGM to approve Migration
19th Jun 20257:00 amRNSPublication of Annual Report and Notice of AGM
17th Jun 20257:00 amRNSCEO Purchase of Shares
12th Jun 20255:00 pmRNSDirector/PDMR Purchase of Shares
12th Jun 202510:30 amRNSDirector Share Options
4th Jun 20257:00 amRNSFY25 Preliminary Results
2nd Jun 20256:24 pmRNSTotal Voting Rights
19th May 20255:30 pmRNSTR1: Major Holdings in Company
15th May 20257:00 amRNSAppointment of Tjeerd Jegen as CEO
30th Apr 20257:00 amRNSDirectorate Change
15th Apr 20257:00 amRNSFY25 Post Close Trading Statement
11th Apr 20259:00 amRNSTR1- Major Shareholding Notification
8th Apr 202511:15 amRNSTR1- Major Shareholding Notification
3rd Apr 20256:15 pmRNSTotal Voting Rights - Correction
1st Apr 202512:30 pmRNSTotal Voting Rights
27th Mar 20254:00 pmRNSTR1 - Major Shareholding Notification
24th Mar 202512:00 pmRNSNotice of FY25 Post Close Trading Statement
27th Feb 20257:45 amRNSDirector/PDMR Purchase of Shares
24th Feb 20257:00 amRNSDirectorate Change and Update on FY25 Guidance
19th Feb 20259:00 amRNSTR1 Major Shareholding Notification
7th Feb 20259:00 amRNSTR1 Major Shareholding Notification
3rd Feb 20255:00 pmRNSTR1 Major Shareholding Notification
30th Jan 20255:30 pmRNSTR1 Major Shareholding Notification
24th Jan 202511:00 amRNSTR1 Major Shareholding Notification
20th Jan 202510:45 amRNSResult of OGM
14th Jan 20255:33 pmRNSBlock Listing Six Monthly Return
13th Jan 20254:00 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNS3rd Quarter Trading Update
18th Dec 20248:31 amRNSNotice of Ordinary General Meeting
17th Dec 20249:15 amRNSBoard Appointment
10th Dec 202410:30 amRNSTiming of Announcement of Q3 Trading Statement
9th Dec 20244:00 pmRNSDirector Purchase of Shares
22nd Nov 20244:02 pmRNSDirector Exercise of Share Options
22nd Nov 20244:00 pmRNSDirector Purchase of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.